肠内营养市场概况、增长、趋势、分析、研究报告(2022-2030 年)

  • Report Code : TIPRE00004763
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 233
Buy Now

Enteral Nutrition Market Share, Size, Trends and Revenue Forecast 2030

Buy Now

 

肠内营养市场规模预计将从 2022 年的 82.7693 亿美元激增至 2030 年的 132.0419 亿美元;预计 2022-2030 年期间市场复合年增长率为 6.0%。

 

分析师观点:

癌症、糖尿病和心血管疾病等慢性病的发病率不断上升,以及新产品的推出推动了肠内营养市场的发展。人们对癌症的认识不断提高,以及在疾病治疗期间和之后对适当营养摄入的要求也使肠内营养市场受益。各国政府也在采取措施,鼓励接受癌症治疗的人群采用肠内营养。例如,加拿大癌症协会正在提高癌症患者对肠内营养和管饲的认识。此外,BC 家庭肠内营养 (HEN) 计划与 Oley 基金会合作,通过宣传、教育和网络提高认识,为不列颠哥伦比亚省和育空地区有特殊营养需求的患者提供支持,帮助患者过上更好的生活。肠内营养市场的主要参与者正专注于新产品的研发和这些产品的推出。2020 年 11 月,雅培推出了含有 2'-岩藻糖基乳糖寡糖的 Similac Pro-Advance。这是加拿大推出的第一款可用作婴儿配方奶粉新成分的肠内营养产品。

 

市场概况:

当患者无法通过日常饮食获得健康生活方式所需的足够营养时,可以接受肠内营养。肠内营养是指任何使用胃肠道 (GI) 输送营养和热量以满足个人热量需求的喂养方法。它可以包括正常的口服饮食、液体补充剂或使用管子输送(管饲)。它适用于能量和营养需求无法通过常规食物摄入满足的患者。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

肠内营养市场:

肠内营养市场
  • Enteral Nutrition Market
    复合年增长率(2022 - 2030 年)
    6.0%
  • 2022 年市场规模
    82.8 亿美元
  • 2030 年市场规模
    132 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 雀巢
  • 达能公司
  • 雅培实验室
  • 荷兰菲仕兰
  • 费森尤斯集团
  • B. Braun SE
  • Dr. Schär AG
  • Arla食品
  • 利洁时

区域概况

Enteral Nutrition Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Enteral Nutrition Market产品类别
  • 一般及疾病特异性
Enteral Nutrition Market应用
  • 胃肠道疾病
  • 代谢/先天性代谢缺陷
  • 食物过敏
  • 肾脏疾病
  • 肝病
  • 肿瘤学
  • 神经病学
  • 其他的
Enteral Nutrition Market年龄阶层
  • 成人和儿童
Enteral Nutrition Market分销渠道
  • 医院药房
  • 零售店
  • 电子商务
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场驱动因素:

 

营养不良和早产病例增加推动全球肠内营养市场

营养不良包括营养不足、超重或肥胖、缺乏维生素或矿物质以及因饮食不良而患上非传染性疾病。根据世界卫生组织 (WHO) 的数据,2021 年全球约有 19 亿成年人超重或肥胖,而体重不足的人数为 4.62 亿。此外,3900 万 5 岁以下儿童超重,1.49 亿儿童因饮食中长期缺乏营养丰富的食物而生长发育迟缓,4500 万人体质虚弱(身高太瘦)。根据需要通过肠内和肠外方式提供营养支持是治疗大多数营养不良病例的重要且合适的方法。因此,儿童和成人营养不良的巨大负担推动了对肠内营养配方和产品的需求。

早产是指婴儿出生过早,即在怀孕 37 周之前出生。根据世界卫生组织 2023 年发布的数据,2020 年全球报告的早产病例约为 1340 万例(超过十分之一)。此外,2021 年大多数早产(超过 60%)发生在南亚和撒哈拉以南非洲,这正成为一个全球关注的问题。平均而言,低收入国家有 12% 的婴儿早产,而高收入国家这一比例为 9%。大量早产儿体重过轻且免疫力不发达,这会危及他们的生命。大多数医学指南建议,如果早产儿无法喝水、吸吮、吞咽和呼吸,则采用肠内营养来支持其最佳生长。此外,由于早产并发症导致吸吮或吞咽困难,或者由于神经肌肉、心脏或其他疾病,此类婴儿更适合采用肠外营养。因此,早产数量的增加正在推动全球肠内营养市场的增长。

 

节段分析:

根据产品类型,肠内营养市场分为一般和疾病特定。一般细分市场在 2022 年占有较大的市场份额。疾病特定产品类型预计在 2022-2030 年期间的复合年增长率将达到 6.1%。一般或标准配方或全蛋白配方是为消化正常的成人或儿童设计的。标准配方包括维持健康所需的所有营养素。一些标准配方可用于肠内喂养和肠外喂养。标准配方从蛋白质来源提供 10-25% 的能量,包括牛奶、乳清、酪蛋白、酪蛋白酸盐或大豆蛋白。配方中的蛋白质提供 4 kcal/gm。标准喂养配方通常耐受性良好,含有完整的蛋白质和长链脂肪。通常需要高热量配方(1.5-2.0 kcal/ml)来提供足够的能量。这些配方适用于需要营养来维持健康并患有消化问题的患者。雀巢和雅培是提供标准蛋白质肠内营养配方的公司之一。雅培生产的 Jevity 1.0 Cal 由牛奶和大豆蛋白组成。它是一种含有纤维的标准蛋白质产品,适合乳糖不耐症患者。

 

区域分析:

北美是肠内营养市场的主导地区。2022 年北美肠内营养市场价值为 32.0658 亿美元,预计到 2030 年将达到 51.8748 亿美元;预计 2022-2030 年复合年增长率为 6.2%。北美肠内营养市场分为美国、加拿大和墨西哥。慢性病患病率上升、市场参与者战略发展不断增加以及对肠内和肠外营养的偏好不断增加,促进了该地区肠内营养市场的进步。此外,个人对管饲等医疗营养在治疗慢性健康状况方面的益处的认识不断提高,进一步促进了肠内营养市场的增长。美国政府正在努力通过举措让人们了解肠内营养。例如,喂食管意识基金会提高了人们对采用喂食管作​​为救命医疗干预措施的认识,并帮助管饲儿童的父母。该基金会于 2019 年 2 月 4 日至 2 月 8 日庆祝了一年一度的喂食管宣传周。此外,Nutricia 和许多类似的公司致力于提高民众的意识。2023 年 1 月,雀巢健康科学投资约 4300 万美元扩建其位于美国威斯康星州欧克莱尔的制造工厂。为了扩建该工厂,该公司将增加两条新生产线,以加强一系列医疗营养产品的生产,例如管饲配方奶粉和营养饮料。2021 年 2 月,美诺医疗集团的 Puggle 肠内喂养泵和儿科和成人患者喂养套件获得了 FDA 510(k) 批准。

欧洲占据肠内营养市场的第二大份额。该地区市场的增长主要归因于老年人口的增加、慢性病和中风、脑动脉瘤等神经系统疾病发病率的上升,以及该地区参与者的产品创新。据德国科学医学协会称,患有严重胃肠道缺陷(如放射性肠炎)的患者可以从肠外营养中受益。在大多数情况下,人工营养可以稳定或增加体重和体脂量。当地市场参与者的存在有利于市场增长。例如,Servona 集团是德国医疗产品、医疗辅助设备和完整家庭护理提供商的顶级制造商之一。它提供肠内营养产品和喂食泵。据该公司称,德国约有 120,000 名患者依赖肠内营养。

亚太地区肠内营养市场复合年增长率最快。推动该地区市场发展的因素包括慢性病患病率上升和该地区市场参与者的不断增加,从而带来了肠内营养产品的最高产量。此外,政府在营养领域的支持性举措和研究促进了市场增长。由于医疗保健行业的不断发展,澳大利亚、印度和韩国等国家预计将迎来各种增长机会。此外,这些国家的政府正在加大提供肠内和肠外营养的力度。在亚太地区,中国占据肠内营养市场的最大份额。神经系统疾病患病率上升和肠内营养的日益普及正在推动市场的增长。中国老年人口显著增加。中风是全国老年人死亡的主要原因。根据爱思唯尔发表的研究,2020 年,报告了 1780 万例中风、340 万例新发中风和 230 万例中风相关死亡病例。中国癌症病例的不断增加推动了肠内营养市场的发展。由于正常食物摄入不足,癌症患者的肠内营养可增加营养摄入。根据世界卫生组织 2020 年 4 月发布的数据,中国新增癌症病例约 4,568,754 例,癌症死亡人数约 3,002,899 人。在中国,每分钟约有 7 人被诊断出患有癌症,4 人死于癌症。

 

关键球员分析:

肠内营养市场分析包括雀巢、达能公司、雅培实验室、菲仕兰坎皮纳、费森尤斯 SE 和 Co. KGaA、B. Braun SE、Dr. Schär AG、Arla Food、利洁时、百利高公司、恒天然合作集团有限公司、Kate Farms 和 Nutritional Medicinals, LLC 等参与者。雅培实验室和费森尤斯卡比公司凭借其多元化的产品组合成为前两大市场参与者。

 

肠内营养市场报告范围

报告属性细节
2022 年市场规模82.8亿美元
2030 年的市场规模132亿美元
全球复合年增长率(2022 - 2030 年)6.0%
历史数据2020-2021
预测期2023-2030
涵盖的领域按产品类型
  • 一般及疾病特异性
按应用
  • 胃肠道疾病
  • 代谢/先天性代谢缺陷
  • 食物过敏
  • 肾脏疾病
  • 肝病
  • 肿瘤学
  • 神经病学
  • 其他的
按年龄组
  • 成人和儿童
按分销渠道
  • 医院药房
  • 零售店
  • 电子商务
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 雀巢
  • 达能公司
  • 雅培实验室
  • 荷兰菲仕兰
  • 费森尤斯集团
  • B. Braun SE
  • Dr. Schär AG
  • Arla食品
  • 利洁时
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

最近的发展:

肠内营养市场中的公司普遍采用并购等无机和有机战略。以下列出了一些近期的关键市场发展:

  • 2023 年 1 月,Nutricia 推出了 Fortimel PlantBased Energy,这是其首款植物基即饮口服营养补充剂。该产品专为满足营养不良人群或因某些疾病而面临营养不良风险的人的营养需求而配制。在推出 Fortimel 之后,该公司计划利用达能(母公司)在植物营养方面的专业知识来扩大其 Fortimel 产品组合。新产品在荷兰、丹麦、挪威、西班牙、芬兰和捷克共和国有售。
  • 2022 年 6 月,雀巢健康科学从 CDH Investments 和 TBHC 创始股东手中收购了 GO Healthy 和 Egmont 的母公司 The Better Health Company (TBHC)。通过此次交易,雀巢健康科学将全资收购 TBHC。其中包括新西兰领先的补品品牌 GO Healthy;位于奥克兰的维生素、矿物质和补品制造工厂新西兰健康制造公司;以及麦卢卡蜂蜜品牌 Egmont。
  • 2022 年 5 月,雀巢健康科学收购了巴西优质营养和健康生活方式品牌 Puravida。通过此次收购,雀巢健康科学打算扩大其在巴西的消费者健康产品组合。Puravida 的产品组合是对雀巢健康科学产品组合的补充,雀巢健康科学在巴西提供口服营养补充剂、蛋白粉和即饮营养饮料。
  • 2021 年 11 月,雅培推出了 Similac 360 Total Care,以支持婴儿的免疫系统、消化健康和大脑发育。Similac 360 Total Care 是美国第一款也是唯一一款混合了五种不同 HMO 的婴儿配方奶粉,这些 HMO 仅在母乳中同时存在。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the enteral nutrition market?

The global enteral nutrition market, based on application, is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest market share in 2022. However, the oncology segment is anticipated to register the highest CAGR during the forecast period.

What was the estimated enteral nutrition market size in 2022?

The enteral nutrition market was valued at US$ 8,276.93 million in 2022.

What are the driving factors for the enteral nutrition market?

The factors driving the growth of the enteral nutrition market include the increase in gastrointestinal disease prevalence and increasing cases of malnutrition and premature births.

What is the enteral nutrition?

Enteral nutrition refers to any method of feeding that uses the gastrointestinal tract to deliver nutrition and calories, including a normal oral diet, liquid supplements, or delivery by tube. According to the American College of Gastroenterology, there are six main feeding tube types. These tubes may have further subtypes depending on exactly where they end in the stomach or intestines.

What are the growth estimates for the enteral nutrition market till 2030?

The enteral nutrition market is expected to be valued at US$ 13,204.19 million in 2030.

Who are the major players in the enteral nutrition market?

The enteral nutrition market majorly consists of the players such as Nestlé, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC.

The List of Companies - Enteral Nutrition Market

  1. Nestlé
  2. Danone S.A.
  3. Abbott Laboratories
  4. FrieslandCampina
  5. Fresenius SE and Co. KGaA
  6. B. Braun SE
  7. Dr. Schär AG
  8. Arla Food
  9. Reckitt Benckiser
  10. Perrigo Company PLC
  11. Fonterra Co-operative Group Limited
  12. Kate Farms
  13. Nutritional Medicinals, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..